| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a6418b21f70fec23765e23e7815dc57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_701f4c0f0e16dabdee8f60ce8b7383f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_857ef81adcae3117f98c0b5020510438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaf71668c34788c123d7e206e0a65cac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_027723f4f69d91fca751b23c7d988393 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16123 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 |
| filingDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6293e5b00954f20cd174036ada1cc538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a586380492a4ca1df75337bebabbf729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e8cddfd469fe470bf2912b9b3e04d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c674a0526e45114adc4b71428abc87a |
| publicationDate |
2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8697088-B2 |
| titleOfInvention |
VLPs derived from cells that do not express a viral matrix or core protein |
| abstract |
The present invention discloses novel influenza virus-like particles (VLPs) that contain chimeric proteins or influenza membrane proteins. The chimeric proteins are derived from fragments of influenza membrane proteins fused to heterologous proteins. The invention includes antigenic formulations and vaccines comprising VLPs of the invention as well as methods of making and administering VLPs to vertebrates, including methods of inducing immunity to infections, such as influenza. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9381239-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11085049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272148-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10358652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11390878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434497-B2 |
| priorityDate |
2007-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |